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ABSTRACT The main aim of this review is to let general practitioners and physicians 
understand what happens to older patients after referral to the renal service. 
Usually, most patients will be managed completely by the renal team, either 
because the patient requires dialysis or because conservative but specialised care 
is appropriate. The recent increase in dialysis rate can mostly be accounted for by 
older patients for whom such demanding treatment was previously thought to be 
contraindicated. The decision to dialyse the elderly still remains difficult, with 
recent data suggesting that if there are significant comorbidities the survival 
advantage of dialysis in patients over 75 years of age is unlikely to be more than 
four months. Towards the end of life, conservative treatment is not simply a 
decision not to dialyse, but comprises active disease management, including 
treatment of anaemia and other supportive care, which may become increasingly 
complex, e.g. pain relief with fentanyl and alfentanyl. Older patients who decide to 
accept dialysis treatment contend with all the usual end of life issues of older 
people. They have an additional option, denied to the rest of us, of dialysis 
withdrawal; this effectively allows them to die at a time of their choosing. 
KeywoRdS Dialysis, older patients, last year of life, palliative care, survival, 
conservative therapy 
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inTRodUCTion
Six years ago, El Nahas and colleagues anticipated that 
‘the worldwide rise in the number of patients with 
chronic kidney disease (CKD) and consequent end-stage 
renal disease requiring renal replacement therapy (RRT) 
threatens to reach epidemic proportions over the next 
decade’.1 Fortunately their alarmist view is incorrect, in 
the UK at least. Most patients with CKD stage 3 do not 
progress to stages 4 or 5, which together account for no 
more than 0.3% of all patients with chronic kidney 
disease.2 In the UK, the dialysis rate in 1981 was under 
27 per million per year3, a figure lower than most 
European countries. Later it seemed that patients were 
never too old for dialysis and the acceptance rate 
quadrupled to 123 per million per year in 2005.4 For the 
five consecutive years since then, Scottish Renal Registry 
data show that the ‘take on’ rate dropped progressively 
and in 2010 stood at 97 per million per year5 (Figure 1). 
The fall in this rate seems likely to be due to fewer older 
patients starting dialysis; in 2007 43% of all patients were 
over 65 years of age, compared to 54% in 2003.4 
This does not mean that the incidence of established 
renal failure in the elderly is declining or that the 
challenge of treating an ever older population has gone 
away. Prevalence data from the Scottish Renal Registry 
show that from 2001 to 2010 there was a year on year 
rise in the total number of patients on RRT.5 Since 
Scottish Government data predict a 70% increase in the 
number of people over 75 between 2008 and 20336, this 
increase in RRT is likely to continue. It is against this 
background that we will review the assessment and 
management of the elderly with advanced kidney 
disease. We start with assessment of renal function and 
treatment options, and then review the latest evidence 
on survival and quality of life, before closing with 
observations on the last year of life, dialysis withdrawal 
and renal palliative care. 
ASSeSSMenT of RenAl fUnCTion
A useful rule of thumb is that every time the creatinine 
doubles, the glomerular filtration rate (GFR) will halve.7 
Thus, if a serum creatinine of 62.5 µmol/l and a GFR of 
100 ml/min is our starting point, this means that when 
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FIGURE 1 Incidence of renal replacement therapy per 
million population. Scottish Renal Registry, 1995–2010.
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Years
the serum creatinine exceeds 500 µmol/l, the GFR will 
have fallen below 12.5 ml/min. No one mourns the 
demise of 24 hour urine collections as the basis for 
calculating creatinine clearance; not only was the 
collection messy and cumbersome but the results 
obtained were frequently inaccurate and misleading. The 
standard method for estimating GFR now is based on 
the MDRD equation derived in the study on modification 
of diet in renal disease which estimates GFR on the basis 
of a patient’s age, serum creatinine, gender and race2. So, 
an 82-year-old white female with serum creatinine of 
300 µmol/l has an estimated glomerular filtration rate 
(eGFR) of 14 ml/min (confidence interval [CI] from 10 
to 18 ml/min). All biochemistry departments in Scotland 
now use this formula to report eGFR, but they do not 
routinely give confidence intervals. The main weakness 
of the MDRD formula is that it takes no account of 
muscle mass, which influences the amount of creatinine 
generated. For patients at extremes of body weight, 
creatinine clearance is best estimated by the Cockcroft 
Gault formula (which takes body weight into account).2 
The take-home message for general physicians and 
geriatricians is that the underweight elderly female with 
serum creatinine 300 µmol/l may well have end-stage 
renal failure.
TReATMenT oPTionS
In theory, all patients with established renal failure have 
the option of hospital haemodialysis, home haemodialysis, 
peritoneal dialysis (PD), transplantation or conservative 
care. In practice, no Scottish patients over the age of 80 
years are currently being treated by home haemodialysis. 
There is no theoretical reason why an elderly renal 
patient should not have a pre-emptive transplant, though 
this also does not happen. If a trial of RRT is chosen, this 
effectively means a choice between hospital-based 
haemodialysis and peritoneal dialysis at home. Studies 
suggest that with appropriate multidisciplinary support, 
over 50% of an elderly population eligible for PD will 
choose this form of treatment.8 However, the uptake is 
much lower.9 A UK Renal Registry analysis of patients 
under 65 years of age on 31 December 2008 showed 
that a third were treated by haemodialysis, 59% had a 
functioning transplant and 8% were undergoing PD. In 
the over 65s the proportion with a functioning transplant 
was 22%, with an increased proportion of hospital 
haemodialysis rather than PD (Figure 2).10
It is likely that in the elderly, physical problems, social 
circumstances and cognitive impairment conspire to 
make PD less attractive. This is ironic given that in a 
recent UK study, scores estimating the intrusion of 
therapy and quality of life were found to be better in PD 
patients than in those who received haemodialysis.11 
Some Scottish units may promote PD more than others, 
as judged by the 2.5-fold variation in uptake reported by 
the Scottish Renal Registry in 2008 (Figure 3).4 A recent 
development has been assisted Automated PD (aAPD)12,13, 
which allows the patient to be treated at night, with a 
portable machine that pumps fluid in and out of their 
peritoneal cavity automatically. With aAPD, a fully trained 
healthcare assistant visits daily – emptying drainage bags, 
checking drained fluid for cloudiness, setting up the 
machine for the next treatment, inspecting the catheter 
exit site and reviewing stocks of treatment fluids and 
drugs. These assistants maintain contact with the parent 
unit which intervenes if problems arise. Latest data 
suggest a near linear increase in aAPD, used for 135 UK 
patients by January 2011.14 
SURViVAl
Some years ago we compared survival of all Scottish 
patients over 80 years of age who were dialysed 
between 1994 and 2001, with age-matched myocardial 
infarction (MI) and lung cancer controls, using data 
supplied by the Information Services Division of the 
Scottish Health Service.15 There were 213 CKD, 14,398 
MI and 4,655 lung cancer patients in this analysis. Median 
survival in days, from 90 days after the start of RRT, 
hospital admission for MI, or cancer diagnosis was 459 
days RRT patients), 1,242 days (MI patients) and 141 days 
(patients with lung cancer). Thus octogenarians who are 
dialysed can anticipate, on average, almost one and a half 
years on dialysis. Similar survival was reported by the 
North Thames Study in 2001, which also showed that 
only age over 80 years and the presence of peripheral 
vascular disease could predict outcome at 12 months.16
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FIGURE 2 UK Renal Registry data showing treatment modality for patients under and over 65 years on 31 December 2008. 
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FIGURE 3 Per cent of renal patients on home therapies 
(excluding transplant) by Scottish Renal Units on 13 December 
2007.  Monk = Monklands; Nine = Ninewells; GRI = Glasgow 
Royal; ARI = Aberdeen Royal; QMH = Queen Margaret Hospital, 
Dunfermline; WIG = Western Infirmary, Glasgow; RIE = Royal 
Infirmary, Edinburgh; XH = Crosshouse; Kilmarnock, DGRI = 
Dumfries & Galloway Royal Infirmary; Raig = Raigmore, Inverness. 
A recent report from the Lister Unit in Stevenage 
revisited the survival of elderly CKD patients in a non-
randomised study.17 Eighty-two per cent (689/844) were 
treated by RRT while 18% (155) received conservative 
management. In these patients, comorbidities (cardiac, 
peripheral vascular, cerebrovascular, diabetes, respiratory, 
cancer and cirrhosis) were assigned severity scores from 
1 to 4. Survival was calculated from the first recorded 
eGFR of less than 15 ml/min, not from the onset of 
dialysis. At first glance it appeared as if patients treated 
by RRT (median survival six years) did much better than 
those who received conservative care (median survival 
2.5 years) but when subjects aged over 75 years were 
analysed separately, with survival adjusted for age, 
gender, ethnicity, and the presence of diabetes or other 
high comorbidities, the median survival advantage 
associated with dialysis fell to four months in the group 
with comorbidities. The take-home message was that 
patients over 75 years of age who received RRT achieved 
a worthwhile survival advantage if there was low 
comorbidity but that median survival if there was high 
comorbidity was poor. 
QUAliTy of life
If the survival advantage of dialysis is not as great as 
hoped for, what kind of quality of life can an elderly 
patient on dialysis expect? We would anticipate that they 
would be susceptible to most of the so-called ‘geriatric 
giants’: infection, immobility, instability, incontinence and 
intellectual impairment. In CKD stage 5, infection is an 
ever-present increased risk, particularly with tunnelled 
lines, while immobility is common, demonstrated by the 
number of patients who attend dialysis in wheelchairs. 
Instability leads to falls and these are greatly increased in 
CKD.18 Urinary incontinence may be a lesser problem 
than in the general population since many dialysis 
patients pass little or no urine. Impaired intellect occurs 
in 13% of patients with an eGFR of less than 30 ml/min; 
when it occurs it adds to the burden of a very demanding 
form of treatment.19 
Quality of life was measured in the North Thames 
Dialysis study using Short Form 36 (SF36) scoring.16 
Physical quality of life was significantly lower in the 
elderly RRT patients than in UK/US age-matched 
populations. In contrast, the emotional quality of life of 
the elderly RRT patients was as good as that of their 
peers in the general population.16 A recent US study 
reported a marked decline of functional status among 
nursing home residents after initiation of dialysis for 
end-stage renal disease.20 Another US study followed the 
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145 patients in hospital on 1 September 2009
59 (41%) died 
within one 
year
5 (8%) 
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30 (51%) 
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Home
86 (59%) alive 
at one year
FIGURE 4 Emergency admissions to medicine in Dumfries 
on 1 September 2009.
progress of all patients 80 years or older who started 
dialysis between 2000 and 2005.21 At the start of RRT, 
78% were living independently at home, 15% were living 
at home with assistance and 6% were already in nursing 
homes. After two years of follow-up only 11% of the 
original cohort (18% of those still alive) were still living 
independently at home. The remainder required 
community or private care support or had been 
transferred to a nursing home.21 
THe lAST yeAR of life
Living and Dying Well, a National Action Plan for Palliative and 
End of Life Care in Scotland, gives clinical prognostic 
indicators for each of the major organ failures that might 
suggest a patient was entering their last year of life.22 For 
CKD the clinical prognostic indicators of the final year 
of life are: 1) CKD stage 5 patients not seeking RRT or 
discontinuing such treatment, from choice, due to frailty 
or too many comorbid conditions and 2) CKD stage 5 
patients whose condition is deteriorating and who are 
likely to die in the next year. The Living and Dying Well 
document also states that comorbidity is the best 
predictor of mortality, giving as measures: weight loss 
>10% in the last six months; general physical decline; 
serum albumin <25 g/l; and dependence on others for 
most activities of daily living.22 
 
A Scottish survey of all patients in an acute hospital on 
31 March 2008 showed that 4,450/14,868 (31%) had 
died by 31 March 2009. The proportion dying within that 
year rose to 38% when the analysis was limited to 
patients aged 65 years and over.  When deaths in the 
over 65s were analysed by specialty it was found that 
deaths in renal medicine (50%) exceeded those of 
general medicine (41%) and of geriatric medicine 
(40%).23 In an analysis of emergency medical admissions 
in Dumfries, 59/145 (41%) of patients who were in 
hospital on 1 September 2009 had died within one year, 
only five (8%) of these having died at home (Figure 4). A 
recent study from Ireland shows the inexorable increase 
in the proportion of deaths occurring in hospitals or 
institutions from 1885 (15%) to 2005 (75%).24 Together, 
these data suggest that we should begin to re-orientate 
our medical practice to meet the palliative and supportive 
care needs of elderly patients with end-stage renal 
disease, more fully, when they are admitted to hospital. 
diAlySiS wiTHdRAwAl
Dialysis withdrawal is probably the most common cause 
of death for patients on RRT. In a French study, 196 of 
1,436 dialysis patients died during follow-up.25 The single 
most common cause of death was dialysis withdrawal 
(defined as death occurring more than three days since 
the last dialysis), which accounted for no fewer than 20% 
of all deaths. Mean survival time after the last treatment 
session was 8.5 days (median seven days). Survival is 
likely to be longer in patients with residual renal 
function. Advanced care planning may not have been 
common in the units investigated because 32 of the 40 
patients in whom dialysis was withdrawn were reported 
as being too weak or ill to participate in the decision. 
Discussion of dialysis withdrawal can be a very sensitive 
issue if it is seen as the withholding of a life-saving 
treatment in an elderly patient. When Professor P 
Hanlon observed in a recent Newsnight interview that 
death was part of the cycle of life and that it might not 
always be appropriate to treat older people in their last 
year intensively26, he received some very negative press. 
However, many elderly dialysis patients perceive their 
quality of life to be much better than we might surmise. 
Nephrologists need to accept that, though it may not be 
what we would wish for ourselves, some patients may be 
very content to sit surrounded by their family. There also 
needs to be debate about whether the National Health 
Service (NHS) can afford such an expensive and 
demanding treatment for people with restrictions on 
their day to day lives.
RenAl PAlliATiVe CARe
For elderly dialysis patients, renal palliative care should 
begin at the time of diagnosis and continue throughout 
the rest of the patient’s life. The elements of such disease 
care include symptom control, psychosocial and spiritual 
support, in addition to  consideration of the particular 
ethical issues of dialysis.27 The National Service 
Framework for Renal Services states that people with 
established renal failure should receive ‘timely evaluation 
of their prognosis, information about the choices 
available to them, and for those near the end of life, a 
jointly agreed palliative care plan, built around their 
individual needs and preferences’.28 Good renal palliative 
care should include advanced care planning even if most 
renal patients appear reluctant to consider this option. 
Renal palliative care then continues with attention to 
symptoms that are often under-recognised. A systematic 
review of 60 studies in 2006 showed the following values 
for weighted mean symptom prevalence in end-stage 
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FIGURE 5 Organ system failure trajectory. 
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renal disease: fatigue/tiredness (71%), pruritis (55%), 
constipation (53%), anorexia (49%), pain (47%), sleep 
disturbance (44%), anxiety (38%), dyspnoea (35%), nausea 
(33%), restless legs (30%), and depression (27%).29 
Multiple symptoms were common in patients on dialysis.
Treatment of symptomatic anaemia with erythropoiesis 
stimulating agents and intravenous iron, one of the renal 
success stories of the last decade, can reduce the need for 
blood transfusions.30 Evidence from the Liverpool Care 
Pathway study suggests that pain is also a frequent 
symptom in patients with end-stage CKD and that pain 
control is often challenging.31 In renal failure, active 
metabolites of morphine accumulate and cause severe 
symptoms (myoclonic jerks, profound narcosis and 
respiratory depression), so before relieving pain we 
should use those opiates that do not accumulate in renal 
disease such as fentanyl or alfentanyl.32 Fentanyl can be 
given by patch, subcutaneously or intravenously, and in 
practice a fentanyl patch, with oxycodone orally at home, 
or alfentanyl subcutaneously in hospital, is usually effective. 
Patients whose pain is not controlled despite such opioids 
should be referred to the palliative care team if this has 
not been done already. 
The trajectory for organ system failure is shown in Figure 
5.33 A gradual decline in function punctuated by hospital 
admissions which become more frequent towards the 
end of life is common in renal failure. Death often seems 
‘sudden’ to many relatives of renal patients even if the 
gradual and progressive decline in that patient’s health has 
been obvious to the hospital team. Most patients whose 
dialysis is withdrawn die after becoming progressively 
more drowsy and slipping into uraemic coma. If death 
occurs suddenly, asystole due to hyperkalaemia is the 
likely trigger. Nausea and dyspnoea can be controlled 
relatively easily by haloperidol, fentanyl or alfentanyl in a 
syringe driver, although pain control may remain 
problematic. One US study showed that only 15% of 
patients had ‘bad deaths’ following the decision to 
terminate dialysis; the study highlighted the complexity of 
decisions to cease treatment and the importance of 
excellent palliative care.34 Many renal units now have renal 
palliative care nurse specialists who are skilled in uraemic 
symptom control and whose remit also includes support 
for the family and carers, both before and after death.35 
ConClUSionS
1. Elderly patients with a serum creatinine of >300 
µmol/l may well have end-stage renal disease, 
especially if they are female and underweight. 
2. Age is not a contraindication to dialysis in the 
elderly but significant comorbidities may be. 
3. Peritoneal dialysis is under-utilised in the elderly, but 
assisted PD may mean that more elderly people can 
be treated in this way. 
4. Dialysis in patients over 80 years of age may prolong 
life by only a few months, if significant comorbidities 
are present. 
5. Emotional quality of life on RRT appears to be as 
good as that of patients of similar age who do not 
have CKD.
6. Renal patients have an option denied to the rest of 
us of dialysis withdrawal, which effectively allows 
them to die at a time of their choosing.
7. Dialysis withdrawal is now the most common cause 
of death for patients on RRT. 
8. Renal palliative care for elderly dialysis patients 
should begin at the time of diagnosis and continue 
throughout life. It differs from non-renal palliative 
care in many respects, not least of which are the 
efficacy of erythropoiesis stimulating agents and 
intravenous iron for renal anaemia and the use of 
fentanyl and alfentanyl for pain control. 
9. A ‘good renal death’ is possible but only if good 
palliative care is available.
While these challenges mainly concern the nephrologist 
who manages chronic renal disease in the elderly, we feel 
that many will also be of interest to other physicians. 
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